Viewing StudyNCT00840931



Ignite Creation Date: 2024-05-05 @ 9:15 PM
Last Modification Date: 2024-10-26 @ 10:01 AM
Study NCT ID: NCT00840931
Status: COMPLETED
Last Update Posted: 2019-12-11
First Post: 2009-02-04

Brief Title: Immunotherapy Using Lenalidomide Bystander Vaccine in High Risk Myelodysplastic Syndrome MDS
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-02-02
Start Date Type: ACTUAL
Primary Completion Date: 2014-02-17
Primary Completion Date Type: ACTUAL
Completion Date: 2019-12
Completion Date Type: ACTUAL
First Submit Date: 2009-02-04
First Submit QC Date: February 10 2009
Study First Post Date: 2009-02-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-10
Last Update Post Date: 2019-12-11
Last Update Post Date Type: ACTUAL